By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AmextaFinanceAmextaFinance
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
AmextaFinanceAmextaFinance
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
AmextaFinance > Investing > Tesla, Sage, Sovos, Veritiv, Tyson, BioNTech, Moderna, and More Market Movers
Investing

Tesla, Sage, Sovos, Veritiv, Tyson, BioNTech, Moderna, and More Market Movers

News Room
Last updated: 2023/08/07 at 10:38 PM
By News Room
Share
3 Min Read
SHARE

Stocks closed higher Monday as Wall Street turned its attention this week to U.S. inflation and how the data will influence the Federal Reserve’s path on interest rates.

These stocks were making moves Monday: 

Tesla
stock (ticker: TSLA) fell 1% after the electric-vehicle giant disclosed that Chief Financial Officer Zachary Kirkhorn stepped down.
Tesla
has appointed Vaibhav Taneja to fill that role, alongside his current role of chief accounting officer.

Sage Therapeutics
(SAGE) tumbled 54% after the biopharmaceutical company and partner
Biogen
(BIIB) failed to receive Food and Drug Administration approval for a treatment of major depressive disorder.
Biogen
shares rose 0.9%.

Shares of
Yellow
(YELL) fell 31% to $2.48 after the trucking company filed for bankruptcy and said it would be closing the business. The stock soared more than 400% last week even as Yellow—one of the country’s largest and oldest trucking companies— was expected to file for bankruptcy.

Shares of
Sovos Brands
(SOVO), the seller of sauces and soups, rose 25% to $22.56 after the firm agreed to be acquired by
Campbell Soup
(CPB) for $23 a share, or a total enterprise value of about $2.7 billion. Sovos also posted better-than-expected second-quarter earnings.

Veritiv
(VRTV) soared 20% to $169.08 after the distributor of packaging and print products said it has agreed to be acquired by an affiliate of private investment firm CD&R. Shareholders will receive $170 a share in cash.

Tyson Foods
(TSN) declined 3.8% after the meat processor reported fiscal third-quarter earnings and revenue below Wall Street’s expectations, and the company recorded a significant quarterly impairment charge on the closure of chicken facilities.

American depositary receipts of
BioNTech
(BNTX), the German company that developed a Covid-19 vaccine with
Pfizer
(PFE), were falling 7.5% after second-quarter revenue missed expectations. Fellow Covid vaccine maker
Moderna
(MRNA) declined 6.5%.

Cloudflare
(NET) fell 2.5% to $67.79 after the cybersecurity company was downgraded to Sell from Neutral at Guggenheim. The analyst also introduced a $50 price target for the stock.

Lucid
(LCID) reduced prices on most of its lineup of Air luxury sedans, and shares of the electric-vehicle maker were falling 3.2%.
Lucid
is scheduled to report earnings after the closing bell Monday.

Warren Buffett’s
Berkshire Hathaway
(BRK.A, BRK.B) reported second-quarter after-tax operating earnings of $10 billion, a quarterly record, up from $9.4 billion a year earlier on strength in insurance underwriting and higher investment income. Net income was $35.9 billion, swinging from a year-earlier loss of $43.6 billion. Stock repurchases in the second quarter were $1.4 billion, compared with $4.4 billion in the first quarter and $1 billion a year earlier. Berkshire Hathaway’s class B shares rose 3.6% to $362.49.

Write to Joe Woelfel at [email protected] 

Read the full article here

News Room August 7, 2023 August 7, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Why Corcept Therapeutics’ Relacorilant Fell Short And What It Means For The Company

This article was written byFollowBioTechAnalyzer is a research and analytics platform focused…

How Build-a-Bear went from a penny stock to a retail winner

Watch full video on YouTube

@TheSharkDaymond reveals “the pitch that got away.”

Watch full video on YouTube

Watts Water Technologies: Hold Rated For The Near Term Because Of Uncertainties

This article was written byFollowI’m a fundamental, valuation-driven investor with a strong…

How AI is influencing the Federal Reserve

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Why Home Builders Are Bouncing Today—and Why Their Stocks Are Good Buys

By News Room
Investing

This Beaten-Down Industrial Stock Wants to Call America Home. Why It’s Time to Buy.

By News Room
Investing

These 8 Dividend Aristocrats Can Protect Your Portfolio in a Downturn

By News Room
Investing

Some Lenders Benefit From SBA’s Troubled Loan Program

By News Room
Investing

Social Security Is in Turmoil. Should You Lock In Benefits Now?

By News Room
Investing

Hims & Hers Stock Is Due for a Crash Diet. The GLP-1 Surge Is Fading Fast.

By News Room
Investing

Opinion: The stock-market selloff isn’t over yet. Here are 4 reasons why.

By News Room
Investing

With Trump’s tariffs paused, ‘Big Three’ automakers may race to build inventories

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

YOUR EMAIL HAS BEEN CONFIRMED.
THANK YOU!

Welcome Back!

Sign in to your account

Lost your password?